Literature DB >> 22001077

Prolonged effects of intracerebroventricular angiotensin II on drinking, eating and locomotor behavior in mice.

Tae Nakano-Tateno1, Masayoshi Shichiri, Noriko Suzuki-Kemuriyama, Yuji Tani, Hajime Izumiyama, Yukio Hirata.   

Abstract

The effects of centrally administered Angiotensin II (Ang II) on water and food intake in rodent models are well known. However, most studies have focused on the acute effects of intracranial Ang II. In the current study, we evaluated the effects of intracerebroventricular Ang II on food and water intake as well as locomotor activity over the entire dark phase of the murine diurnal cycle. Consistent with the previous reports, centrally administered Ang II rapidly stimulated water intake over the initial 1-hour period following treatment. However, this acute increase was immediately followed by a marked reduction in water intake resulting in decreased cumulative water intake approximately 7h after Ang II treatment. Pretreating animals with an Ang II type 1 receptor blocker, Losartan, completely antagonized the acute effect of Ang II and abolished initial water intake. In contrast, application of an Ang II type 2 receptor blocker, PD123319, abrogated the prolonged inhibitory effect of Ang II on drinking behavior and partially suppressed the initial increases in water intake. The suppressive effects of Ang II on cumulative food intake and spontaneous physical activity were also evident throughout the entire dark phase of diurnal cycle. These experiments are the first to suggest that the stimulatory effect of central Ang II treatment on water consumption is very temporary and that it causes a sustained suppressive effect on voluntary locomotion and food intake behavior in mice.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001077     DOI: 10.1016/j.regpep.2011.09.011

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

1.  ANGT_HUMAN[448-462], an Anorexigenic Peptide Identified Using Plasma Peptidomics.

Authors:  Sayaka Sasaki; Kazuhito Oba; Yoshio Kodera; Makoto Itakura; Masayoshi Shichiri
Journal:  J Endocr Soc       Date:  2022-05-19

Review 2.  Brain angiotensin converting enzyme-2 in central cardiovascular regulation.

Authors:  Mazher Mohammed; Clara Berdasco; Eric Lazartigues
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.124

Review 3.  Influence of gestational salt restriction in fetal growth and in development of diseases in adulthood.

Authors:  Hiroe Sakuyama; Minami Katoh; Honoka Wakabayashi; Anthony Zulli; Peter Kruzliak; Yoshio Uehara
Journal:  J Biomed Sci       Date:  2016-01-20       Impact factor: 8.410

4.  Salusin-β as a powerful endogenous antidipsogenic neuropeptide.

Authors:  Noriko Suzuki-Kemuriyama; Tae Nakano-Tateno; Yuji Tani; Yukio Hirata; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

5.  MRI/DTI of the Brain Stem Reveals Reversible and Irreversible Disruption of the Baroreflex Neural Circuits: Clinical Implications.

Authors:  Chia-Hao Su; Ching-Yi Tsai; Alice Y W Chang; Julie Y H Chan; Samuel H H Chan
Journal:  Theranostics       Date:  2016-04-11       Impact factor: 11.556

6.  Suprabasin-derived bioactive peptides identified by plasma peptidomics.

Authors:  Tomomi Taguchi; Yoshio Kodera; Kazuhito Oba; Tatsuya Saito; Yuzuru Nakagawa; Yusuke Kawashima; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.